Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

HeartSciences (HSCSW) Equity Ratio (2022 - 2025)

Historic Equity Ratio for HeartSciences (HSCSW) over the last 4 years, with Q4 2025 value amounting to 0.7.

  • HeartSciences' Equity Ratio rose 3505.69% to 0.7 in Q4 2025 from the same period last year, while for Oct 2025 it was 0.7, marking a year-over-year increase of 3505.69%. This contributed to the annual value of 0.05 for FY2025, which is 9369.01% down from last year.
  • Per HeartSciences' latest filing, its Equity Ratio stood at 0.7 for Q4 2025, which was up 3505.69% from 0.49 recorded in Q3 2025.
  • HeartSciences' 5-year Equity Ratio high stood at 0.8 for Q1 2024, and its period low was 2.9 during Q2 2022.
  • Moreover, its 4-year median value for Equity Ratio was 0.31 (2025), whereas its average is 0.09.
  • In the last 5 years, HeartSciences' Equity Ratio crashed by 40692.7% in 2023 and then skyrocketed by 117869.77% in 2024.
  • Over the past 4 years, HeartSciences' Equity Ratio (Quarter) stood at 0.23 in 2022, then tumbled by 406.93% to 0.7 in 2023, then surged by 174.15% to 0.52 in 2024, then soared by 35.06% to 0.7 in 2025.
  • Its Equity Ratio stands at 0.7 for Q4 2025, versus 0.49 for Q3 2025 and 0.05 for Q2 2025.